
Immuno-oncology and immunotherapy Part A
Series: Methods in Cell Biology; 189;
- Publisher's listprice EUR 160.00
-
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 6 787 Ft off)
- Discounted price 61 085 Ft (58 176 Ft + 5% VAT)
67 872 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Academic Press
- Date of Publication 24 October 2024
- ISBN 9780443296222
- Binding Hardback
- No. of pages220 pages
- Size 228x152 mm
- Weight 490 g
- Language English 656
Categories
Long description:
Immuno-Oncology And Immunotherapy - Part A Volume 189, in the Methods in Cell Biology series, continues the legacy of this premier serial with quality chapters authored by leaders in the field. Specific chapters to this release include, Generation of transmitochondrial cybrids in cancer cells, Methods for flow cytometry analysis for tumor infiltrating cells functions and phenotype, Innovative 2D and 3D methods of tumor cells culture, and more.
MoreTable of Contents:
1. Assessment of translation rate in leukemic cells and immune cells of the microenvironment by OPP protein synthesis assay
Vanessa Klapp, Ozgu Gumustekin, Jérôme Paggetti, Etienne Moussay and Anne Largeot
2. Generation of transmitochondrial cybrids in cancer cells
Ruth Soler-Agesta, Cristina Ripollés-Yuba, Joaquín Marco-Brualla, Raquel Moreno-Loshuertos, Ai Sato, Manuel Beltrán-Visiedo, Lorenzo Galluzzi and Alberto Anel
3. Enzyme-linked Immunospot (Elispot) assay to quantify peptide-specific IFN-? production by splenocytes in a mouse tumor model after radiation therapy
Benoît Lecoester, Yaoyao Xie, Amélie Marguier, Laura Boulerot, Marine Malfroy, Olivier Adotévi and Jihane Boustani
4. Tumor slice culture system for ex vivo immunotherapy studies
Leire Arrizabalaga, Joan Salvador Russo-Cabrera, Virginia Belsúe, Pedro Berraondo, Ignacio Melero and Fernando Aranda
5. Identification and analysis of alloreactive T lymphocytes from peripheral blood mononuclear cells
Alberto Susana, Giovanni Galletti, Gabriele De Simone, Chiara Camisaschi and Enrico Lugli
6. Assessment of pDCs functional capacity upon exposure to tumor-derived soluble factors
Vladimír Koucký, Linn A. Syding, Klára Placková, Lucie Pavelková and Anna Fialová
7. Degranulation assay to evaluate NK cell natural and antibody-dependent cell-mediated cytotoxicity against A549 tumor spheroids
Ainara Lopez-Pardo, Ainhoa Amarilla-Irusta, Víctor Sandá, Mario Stan, Francisco Borrego and Laura Amo
8. Characterization of Natural Killer cells infiltrating irradiated murine tumors through flow cytometry
Jérémy Baude, Riad Ladjohounlou, Emeric Limagne, Lisa Froidurot, Véronique Morgand and Céline Mirjolet
9. Flow cytometry detection and quantification of circulating leukocyte subpopulations in mice after brain irradiation
Julie Coupey, Marine M. Leblond, Erika S. Hue and Samuel Valable
10. Flow cytometry-assisted analysis of phenotypic maturation markers on an immortalized dendritic cell line
Ginevra Campia, Manuel Beltrán-Visiedo, Ruth Soler-Agesta, Ai Sato, Norma Bloy, Liwei Zhao, Peng Liu, Oliver Kepp, Guido Kroemer, Lorenzo Galluzzi and Claudia Galassi
11. Optimization and intra-assay validation of a multiparametric flow cytometric test for monitoring circulating TREGs
Iole Macchia, Floriana Iacobone and Francesca Urbani
12. Cytofluorometric assessment of calreticulin exposure on CD38+ plasma cells from the human bone marrow
Manuel Beltrán-Visiedo, Alfonso Serrano-Del Valle, Nelia Jiménez-Aldúan, Ruth Soler-Agesta, Javier Naval, Lorenzo Galluzzi and Isabel Marzo
More
The Europa World of Learning 2020
759 150 HUF

Immuno-oncology and immunotherapy Part A
67 872 HUF

The Europa World of Learning 2021
480 795 HUF

The Europa World of Learning 2025
809 760 HUF